Retinal blood flow in mild cognitive impairment and Alzheimer's disease

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

Volumn 1, Issue 2, 2015, Pages 144-151

  Feke, Gilbert T ^a   Hyman, Bradley T ^b   Stern, Robert A ^c   Pasquale, Louis R ^a,d  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Mild cognitive impairment; Retinal blood flow; Retinal blood speed; Retinal venous blood column diameter

Indexed keywords

EID: 84938682524     PISSN: None     EISSN: 23528729     Source Type: Journal    
DOI: 10.1016/j.dadm.2015.01.004     Document Type: Article

References (42)

1. Ruitenberg A., den Heijer T., Bakker S.L., van Swieten J.C., Koudstall P.J., Hofman A., et al. Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study. Ann Neurol 2005, 57:789-794.
2. Austin B.P., Nair V.A., Meier T.B., Xu G., Rowley H.A., Carlson C.M., et al. Effects of hypoperfusion in Alzheimer's disease. J Alzheimer's Dis 2011, 26:123-133.
3. Brown W.R., Thore C.R. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 2011, 37:56-74.
4. Hunter J.M., Kwan J., Malek-Ahmadi M., Maarouf C.L., Kokjohn T.A., Belden C., et al. Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease. PLos One 2012, 7:e36893.
5. Mazza M., Marano G., Traversi G., Bria P., Mazza S. Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. J Alzheimer's Dis 2011, 23:375-389.
6. de la Torre J.C., Stefano G.B. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res Rev 2000, 34:119-136.
7. Katusic Z.S., Austin S.A. Endothelial nitric oxide: protector of a healthy mind. Eur Heart J 2014, 35:888-894.
8. Maalikjy Akkawi N., Borroni B., Agosti C., Magoni M., Broli M., Pezzini A., et al. Volume cerebral blood flow reduction in pre-clinical stage of Alzheimer disease: evidence from an ultrasonographic study. J Neurol 2005, 252:559-563.
9. Park K.W., Yoon H.J., Kang D.Y., Kim B.C., Kim S.Y., Kim J.W. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease. Psychiatry Res 2012, 203:201-206.
10. Hirao K., Ohnishi T., Hirata Y., Yamashita F., Mori T., Moriguchi Y., et al. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 2005, 28:1014-1021.
11. Hansson O., Buchhave P., Zetterberg H., Blennow K., Minthon L., Warkentin S. Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging 2009, 30:165-173.
12. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 2004, 16:206-214.
13. Girouard H., Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer's disease. J Appl Physiol (1985) 2006, 100:328-335.
14. Patton N., Aslam T., MacGillivray T., Pattie A., Deary I.J., Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat 2005, 206:319-348.
15. Ikram M.K., Cheung C.Y., Wong T.Y., Chen C.P. Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2012, 83:917-922.
16. Guo L., Duggan J., Cordeiro M.F. Alzheimer's disease and retinal neurodegeneration. Curr Alzheimer Res 2010, 7:3-14.
17. Frost S., Kanagasingam Y., Sohrabi H., Vignarajan J., Bourgeat P., Salvado O., et al. Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease. Transl Psychiatry 2013, 3:e233. 10.1038/tp.2012.150.
18. Cheung C.Y., Ong Y.T., Ikram M.K., Ong S.Y., Li X., Hilal S., et al. Microvascular network alterations in the retina of patients with Alzheimer's disease. Alzheimers Dement 2014, 10:135-142.
19. Berisha F., Feke G.T., Trempe C.L., McMeel J.W., Schepens C.L. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci 2007, 48:2285-2289.
20. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004, 256:183-194.
21. Diagnostic and Statistical Manual of Mental Disorders - fourth edition (DSM-IV) 1994, American Psychiatric Association, Washington D.C.
22. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
23. Yoshida A., Feke G.T., Mori F., Nagaoka T., Fujio N., Ogasawara H., et al. Reproducibility and clinical application of a newly developed stabilized retinal laser Doppler instrument. Am J Ophthalmol 2003, 135:356-361.
24. Huang D., Swanson E.A., Lin C.P., Schuman J.S., Stinson W.G., Chang W., et al. Optical coherence tomography. Science 1991, 254:1178-1181.
25. Hee M.R., Izatt J.A., Swanson E.A., Huang D., Schuman J.S., Lin C.P., et al. Optical coherence tomography of the human retina. Arch Ophthalmol 1995, 113:325-332.
26. Nagaoka T., Sato E., Takahashi A., Yokota H., Sogawa K., Yoshida A. Impaired retinal circulation in patients with type 2 diabetes mellitus: retinal laser Doppler velocimetry study. Invest Ophthalmol Vis Sci 2010, 51:6729-6734.
27. Berisha F., Feke G.T., Hirose T., McMeel J.W., Pasquale L.R. Retinal blood flow and nerve fiber layer measurements in early-stage open-angle glaucoma. Am J Ophthalmol 2008, 146:466-472.
28. Ellis R.J., Olichney J.M., Thal L.J., Mirra S.S., Morris J.C., Beekly D., et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, part XV. Neurology 1996, 46:1592-1596.
29. Vinters H.V., Wang Z.Z., Secor D.L. Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol 1996, 6:179-195.
30. Jellinger K.A. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 2002, 109:813-836.
31. Tian J., Shi J., Smallman R., Iwatsubo T., Mann D.M. Relationships in Alzheimer's disease between the extent of Aβ deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen. Neuropathol Appl Neurobiol 2006, 32:332-340.
32. Thal D.R., Griffin W.S., Braak H. Parenchymal and vascular Aβ-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease. J Cell Mol Med 2008, 12:1848-1862.
33. Kalaria R.N., Pax A.B. Increased collagen content of cerebral microvessels in Alzheimer's disease. Brain Res 1995, 705:349-352.
34. Brown W.R., Moody D.M., Thore C.R., Challa W.R. Cerebrovascular pathology in Alzheimer's disease and leukoaraiosis. Ann N Y Acad Sci 2000, 903:39-45.
35. Brown W.R., Moody D.M., Challa V.R., Thore C.R., Anstrom J.A. Venous collagenosis and arteriolar tortuosity in leukoaraiosis. J Neurol Sci 2002, 203-204:159-163.
36. Embleton S.J., Hosking S.L., Roff Hilton E.J., Cunliffe I.A. Effect of senescence on ocular blood flow in the retina, neuroretinal rim and lamina cribrosa, using scanning laser Doppler flowmetry. Eye 2002, 16:156-162.
37. Groh M.J., Michelson G., Langhans M.J., Harazny J. Influence of age on retinal and optic nerve head blood circulation. Ophthalmology 1996, 103:529-534.
38. Grunwald J.E., Piltz J., Patel N., Bose S., Riva C.E. Effect of aging on retinal macular microcirculation: a blue field simulation study. Invest Ophthalmol Vis Sci 1993, 34:3609-3613.
39. Trick G.L., Trick L.R., Morris P., Wolf M. Visual field loss in senile dementia of the Alzheimer's type. Neurology 1995, 45:68-74.
40. Paquet C., Boissonnot M., Roger F., Dighiero P., Gil R., Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer disease. Neurosci Lett 2007, 420:97-99.
41. de la Torre J.C. Alzheimer's disease: how does it start?. J Alzheimer's Dis 2002, 4:497-512.
42. Aliev G. Is non-genetic Alzheimer's disease a vascular disorder with neurodegenerative consequences?. J Alzheimer's Dis 2002, 4:513-516.